Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia

listen audio

Study Justification:
– The study aimed to assess the perspectives of health workers and policy-makers on the use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.
– The use of intramuscular artesunate as a pre-referral treatment could be lifesaving, especially in areas where referral is delayed or not possible.
– The study aimed to gather evidence on the safety, feasibility, and efficacy of using intramuscular artesunate at health posts to guide policy decisions.
Study Highlights:
– Provision of intramuscular artesunate as pre-referral and definitive treatment for severe malaria at health posts could be lifesaving.
– Health posts can provide definitive treatment for severe malaria using intramuscular artesunate with adequate training and provision of facilities.
– Health workers find the intramuscular route easier to use at the health post level compared to the intravenous route.
– Common reasons against the use of intramuscular artesunate at health posts include lack of capacity to manage complications and fear of irrational drug use.
– The use of intramuscular artesunate at health posts will require evidence on safety and feasibility before any policy shift.
Recommendations for Lay Reader and Policy Maker:
– The use of intramuscular artesunate as a pre-referral treatment for severe malaria at health posts should be considered, as it could save lives in areas with delayed or no referral options.
– Health workers at health posts should receive adequate training and facilities, including beds, to provide definitive treatment for severe malaria using intramuscular artesunate.
– Further operational research is needed to establish the feasibility, safety, and efficacy of using intramuscular artesunate as definitive treatment at health posts before any implementation.
Key Role Players Needed to Address Recommendations:
– Health workers: They need to be trained in the use of intramuscular artesunate and provided with necessary facilities to administer the treatment.
– Regional Health Bureaus: They play a role in coordinating and supporting the implementation of new treatment guidelines.
– Federal Ministry of Health: They are responsible for developing and updating national malaria treatment guidelines based on evidence and recommendations.
– Development partners: They can provide technical and financial support for training programs and infrastructure improvement.
Cost Items to Include in Planning Recommendations:
– Training programs for health workers on the use of intramuscular artesunate.
– Provision of necessary facilities, including beds, at health posts.
– Monitoring and evaluation activities to assess the safety, feasibility, and efficacy of using intramuscular artesunate at health posts.
– Research studies to gather evidence on the impact and effectiveness of the intervention.
– Coordination and support activities by the Regional Health Bureaus and Federal Ministry of Health.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong, but there are some areas for improvement. The study provides insights from 101 individuals, including health workers, malaria focal persons, and policy-makers, which adds credibility to the findings. The study was conducted in two regions of Ethiopia with high malaria burden, which enhances the generalizability of the results. However, the abstract does not mention the specific methodology used for data collection and analysis, which could be improved by providing more details. Additionally, the abstract does not mention any limitations of the study, which should be included to provide a balanced assessment of the evidence. To improve the strength of the evidence, future studies could consider using a larger sample size and a more diverse range of participants. It would also be beneficial to include a comparison group to assess the effectiveness of intramuscular artesunate compared to other treatment options. Finally, providing more information on the study design, such as whether it was a cross-sectional or longitudinal study, would enhance the clarity of the evidence.

Background: The World Health Organization (WHO) recommends injectable artesunate given either intravenously or by the intramuscular route for definitive treatment for severe malaria and recommends a single intramuscular dose of intramuscular artesunate or intramuscular artemether or intramuscular quinine, in that order of preference as pre-referral treatment when definitive treatment is not possible. Where intramuscular injections are not available, children under 6 years may be administered a single dose of rectal artesunate. Although the current malaria treatment guidelines in Ethiopia recommend intra-rectal artesunate or alternatively intramuscular artemether or intramuscular quinine as pre-referral treatment for severe malaria at the health posts, there are currently no WHO prequalified suppliers of intra-rectal artesunate and when available, its use is limited to children under 6 years of age leaving a gap for the older age groups. Intramuscular artesunate is not part of the drugs recommended for pre-referral treatment in Ethiopia. This study assessed the perspectives of health workers, and policy-makers on the use of intramuscular artesunate as a pre-referral and definitive treatment for severe malaria at the health post level. Methods: In-depth interviews were held with 101 individuals including health workers, malaria focal persons, and Regional Health Bureaus from Oromia and southern nations, nationalities, and peoples’ region, as well as participants from the Federal Ministry of Health and development partners. An interview guide was used in the data collection and thematic content analysis was employed for analysis. Results: Key findings from this study are: (1) provision of intramuscular artesunate as pre-referral and definitive treatment for severe malaria at health posts could be lifesaving; (2) with adequate training, and provision of facilities including beds, health posts can provide definitive treatment for severe malaria using intramuscular artesunate where referral is delayed or not possible; (3) health workers at health centres and hospitals frequently use the intravenous route because it allows for co-administration of other drugs, but they find the intramuscular route easier to use at the health post level; (4) the reasons commonly cited against the management of severe malaria using intramuscular artesunate at health post level were: lack of capacity to manage complications and fear of irrational drug use; (5) use of intramuscular artesunate at health post level will require evidence on safety and feasibility before policy shift. Conclusion: From the perspective of health workers, use of intramuscular artesunate as pre-referral treatment of severe malaria cases at the health post is possible but dependent on training and availability of skilled workers. Use of intramuscular artesunate as definitive treatment at health posts was not supported, however, operational research to establish its feasibility, safety and efficacy was recommended to guide any implementation of such an intervention.

The study was conducted in two regions of Ethiopia, southern nations, nationalities, and peoples’ region (SNNPR), and Oromia from January to March, 2015. Participants were identified from health facilities serving nine malarious areas of the regions, Zonal offices, Regional Health Bureaus, Federal Ministry of Health and partners. Oromia is the most populous region in Ethiopia with a total population of 32 million. SNNPR is the 3rd largest regional state with a total population of 18 million [6]. SNNPR and Oromia regions have the highest malaria burden in Ethiopia [23]. The major health problems of SNNPR and Oromia remain largely preventable communicable diseases and nutritional disorders. The health system priorities are health service delivery at household, community and facility level to improve maternal, neonatal, child, adolescent and youth health, nutrition, hygiene and environmental health, and to reduce/combat HIV/AIDS, tuberculosis and malaria and other communicable and non-communicable diseases [15]. Access to care remains a problem especially in rural areas where the population is characterized by poverty and poor health indicators. The Ethiopian government has endeavored to improve access to care by providing a community based service provided by health extension workers who after a year’s training provide comprehensive preventive and curative services to these remote populations and by equipping health centres with ambulances to provide care for obstetric and other emergencies but referral from health post could be delayed due to poor infrastructure or other emergencies. The Ethiopia health care tiers are presented in Fig. 1. This was a qualitative exploratory study that used in-depth interviews to collect data on the perspectives of health workers, and policy-makers on the use of intramuscular artesunate as a pre-referral and definitive treatment for severe malaria at health posts. A total of 101 respondents were interviewed. A list of all zones from the two regions regarded high burden by the Federal Ministry of Health was used and from this list nine zones with the highest burden were selected. The selected zones were the following: East Shoa, South west Shoa and Jima zone from Oromia region, and Gomgofa, Silti, Kembata Tembaro, Halaba, Wolayita and Hadiya zones from SNNPR. A zone is an administrative area below the region, and includes several districts or woredas. Thirty health facilities from each of the two states (Oromia and SNNPR) were purposively selected to be included in the study if they had large numbers of severe malaria cases reported (according to the routine health facility data reports) and if were easily accessible by the study team. A maximum of two health workers, one health worker involved in management of malaria on the day of the interview and one manager in the selected health facilities were included in the study. In Oromia state, given the busy schedules of the health workers, it was impossible to interview more than one staff at the selected facilities, and two of the selected facilities were not open on the survey day. In SNNPR, all selected facilities were functional and two health workers were interviewed at each of the facilities. At two of the facilities in SNNPR, the team was able to interview both the severe malaria ward manager and well as the health facility manager. In addition, the malaria focal persons from the Zonal health departments, Regional Health Bureau, Federal Ministry of Health, and development partners were also included in the study. The number of respondents interviewed within the different categories are presented in Table 1. Respondents selected by category and region An interview guide was used to collect data from respondents. In-depth interviews were conducted by twenty research assistants with research experience and trained in data collection specifically for this study. The interviews were conducted in the local languages. The research assistants working in pairs approached the managers and asked permission to conduct the study in the health facilities and for guidance on the health workers to be interviewed. Informed consent was then sought from the health workers to participate in the study. Appointments were made for interviews with all other participants at zonal, regional, Federal Ministry of Health and development partners. The research assistants took notes and audio recordings during the interviews. Supervision and guidance to the field teams was provided by two co-investigators with experience conducting qualitative research. Daily supervision of interviewers and checking of completed interviews was done to ensure collection of accurate and complete data. Audio-recorded data were transcribed and then translated from the local languages to Amharic and then into English. Senior researchers read the transcripts and identified emerging themes, and codes. The transcripts were then coded using Atlas.ti7 (Atlas.ti GmbH, Berlin) during the coding process; more codes were identified and discussed by the research team. These codes were merged into categories and then into themes reflecting the study objectives and other emerging issues. Thematic content analysis was employed.

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Mobile health clinics: Implementing mobile health clinics that can travel to remote areas with limited access to healthcare facilities. These clinics can provide prenatal care, postnatal care, and emergency obstetric services to pregnant women.

2. Telemedicine: Utilizing telemedicine technology to connect pregnant women in remote areas with healthcare professionals. This allows for remote consultations, monitoring, and guidance throughout pregnancy and childbirth.

3. Community health workers: Training and deploying community health workers who can provide basic maternal healthcare services, education, and referrals in underserved areas. These workers can act as a bridge between the community and formal healthcare facilities.

4. Improving transportation infrastructure: Investing in better transportation infrastructure, such as roads and ambulances, to ensure timely access to healthcare facilities for pregnant women in remote areas.

5. Task-shifting: Expanding the roles and responsibilities of healthcare workers, such as nurses and midwives, to provide a wider range of maternal healthcare services. This can help alleviate the shortage of doctors in underserved areas.

6. Health information systems: Implementing robust health information systems that can track and monitor maternal health indicators, identify gaps in access to care, and inform targeted interventions.

7. Public-private partnerships: Collaborating with private healthcare providers to expand access to maternal health services in underserved areas. This can involve subsidizing services, providing training and resources, and ensuring quality standards are met.

8. Maternal waiting homes: Establishing maternal waiting homes near healthcare facilities to accommodate pregnant women who live far away. These homes provide a safe and comfortable place for women to stay before and after childbirth, reducing the risk of complications due to delayed access to care.

9. Financial incentives: Introducing financial incentives, such as cash transfers or insurance schemes, to encourage pregnant women to seek timely and appropriate maternal healthcare services.

10. Community engagement and education: Conducting community engagement activities and educational campaigns to raise awareness about the importance of maternal healthcare, dispel myths and misconceptions, and promote early and regular antenatal care visits.
AI Innovations Description
The study mentioned in the description focuses on the perspectives of health workers and policy-makers on the use of intramuscular artesunate as a pre-referral and definitive treatment for severe malaria at health posts in Ethiopia. The study found that providing intramuscular artesunate as pre-referral and definitive treatment at health posts could be lifesaving. However, there are challenges such as lack of capacity to manage complications and fear of irrational drug use. The study recommends conducting operational research to establish the feasibility, safety, and efficacy of using intramuscular artesunate at health posts for the management of severe malaria. This research would provide evidence to guide any implementation of such an intervention.

The study was conducted in two regions of Ethiopia, southern nations, nationalities, and peoples’ region (SNNPR), and Oromia. These regions have the highest malaria burden in Ethiopia. Access to care, especially in rural areas, remains a problem due to poor infrastructure and other emergencies. The Ethiopian government has taken steps to improve access to care by providing community-based services through health extension workers and equipping health centers with ambulances. However, referral from health posts can be delayed. The study aims to explore the perspectives of health workers and policy-makers to identify potential solutions to improve access to maternal health in these regions.

The study used in-depth interviews with health workers, malaria focal persons, Regional Health Bureaus, the Federal Ministry of Health, and development partners. A total of 101 respondents were interviewed from selected health facilities in the two regions. The interviews were conducted in the local languages, and the data were transcribed, translated, and analyzed using thematic content analysis.

Overall, the study highlights the potential of using intramuscular artesunate at health posts for the management of severe malaria. However, further research is needed to address the challenges and ensure the feasibility, safety, and efficacy of this intervention. This research can contribute to improving access to maternal health in Ethiopia, particularly in rural areas with limited healthcare infrastructure.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations to improve access to maternal health:

1. Training and capacity building: Provide comprehensive training programs for health workers on maternal health, including the management of severe malaria using intramuscular artesunate. This will ensure that health workers have the necessary skills and knowledge to provide appropriate care.

2. Availability of facilities and resources: Ensure that health posts have the necessary facilities and resources, such as beds and equipment, to provide definitive treatment for severe malaria using intramuscular artesunate. This will enable health posts to effectively manage severe malaria cases when referral is delayed or not possible.

3. Policy shift and evidence generation: Conduct operational research to establish the feasibility, safety, and efficacy of using intramuscular artesunate as definitive treatment at health posts. This research will provide evidence to support a policy shift and guide the implementation of such an intervention.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the indicators: Identify key indicators that reflect access to maternal health, such as the number of women receiving antenatal care, the number of women receiving skilled birth attendance, and the number of women receiving postnatal care.

2. Collect baseline data: Gather data on the selected indicators before implementing the recommendations. This will provide a baseline against which the impact can be measured.

3. Implement the recommendations: Introduce the recommended interventions, including training programs, provision of facilities and resources, and policy changes.

4. Monitor and evaluate: Continuously monitor the implementation of the recommendations and collect data on the selected indicators. This can be done through routine data collection systems, surveys, or interviews.

5. Analyze the data: Analyze the collected data to assess the impact of the recommendations on the selected indicators. Compare the post-intervention data with the baseline data to determine any changes or improvements.

6. Interpret the findings: Interpret the findings to understand the extent to which the recommendations have improved access to maternal health. Identify any challenges or barriers that may have influenced the results.

7. Adjust and refine: Based on the findings, make any necessary adjustments or refinements to the recommendations to further improve access to maternal health.

By following this methodology, it will be possible to simulate the impact of the recommendations on improving access to maternal health and make informed decisions for future interventions.

Yabelana ngalokhu:
Facebook
Twitter
LinkedIn
WhatsApp
Email